Results 291 to 300 of about 4,484,991 (333)

Generic Drugs

Drug Safety, 1996
For economic reasons, the use of generic substitution is increasingly being supported by health authorities. Potentially, this may be problematic for drugs with a narrow therapeutic window if quality control and/or bioequivalence is not optimal. Many developing countries do not have the resources or expertise to carry out appropriate quality control ...
openaire   +2 more sources

Generic Drugs.

The Medical letter on drugs and therapeutics, 2002
Various incentives will progressively increase the part of generic drugs on the Belgian market place and will more and more confront the prescriber with the problem of substitution. The equivalence between generic and brand name products and the fear, justified or not, at efficacy or patient safety levels in case of substitution are discussed on the ...
  +6 more sources

Generation of Aerosolized Drugs

Journal of Aerosol Medicine, 1994
The expanding use of inhalation therapy has placed demands on current aerosol generation systems that are difficult to meet with current inhalers. The desire to deliver novel drug entities such as proteins and peptides, as well as complex formulations including liposomes and microspheres, requires delivery systems of improved efficiency that will ...
R K, Wolff, R W, Niven
openaire   +2 more sources

Reassurance about Generic Drugs

New England Journal of Medicine, 1987
The approval, marketing, and use of generic pharmaceutical agents in the United States have expanded greatly over the past two years.
G A, Faich, J, Morrison, E V, Dutra, D B, Hare, P H, Rheinstein   +4 more
openaire   +2 more sources

DRUG‐INDUCED GENERALIZED PHOSPHOLIPIDOSIS

Acta Pathologica Japonica, 1972
Drug‐Induced generalized phosphollpldosis in human beings is described. Detailed study of phospholipid fatty liver, which was first reported by us in 1968, disclosed that phospholipid accumulation is not only found in the liver but is also distributed throughout the body.
T, Shikata, T, Kanetaka, Y, Endo, K, Nagashima   +3 more
openaire   +2 more sources

Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic Drugs

Pharmaceutical Research, 2022
Di Wu, Maitri Sanghavi, Sivacharan Kollipara, Tausif Ahmed, A. K. Saini, T. Heimbach   +5 more
semanticscholar   +1 more source

Legal Control of Drugs and Generic Drugs

Nursing, Law & Ethics, 1980
The regulation of the use and distribution of drugs in the United States is governed by a complex set of state and federal laws and regulations. These laws and regulations are designed to accomplish a variety of purposes. First, the federal government hopes to exclude from interstate commerce drugs that are not both “safe and effective.” This function ...
G J, Annas, L H, Glantz, B, Katz
openaire   +2 more sources

The impact of National Centralised Drug Procurement policy on the use of policy-related original and generic drugs in China.

International Journal of Health Planning and Management, 2022
Ying Yang, Runhu Hu, X. Geng, Lining Mao, Xiaotong Wen, Zhaolun Wang, Siyu Hao, D. Cui, Z. Mao   +8 more
semanticscholar   +1 more source

[Generic drugs].

Revue medicale de Bruxelles, 2000
When the term of the patent is completed, medicinal products may be copied. Generic products only refer to "essentially similar specialities". It means that bio-equivalence must be established. Generic medicines are cheaper than branded products involving a major economical issue.
openaire   +3 more sources

Generic Drug Substitution Revisited

New England Journal of Medicine, 1987
IN the past few decades, concern about reducing health care costs has led to attempts to increase the dispensing of generic drug products.
openaire   +2 more sources